Header cover image

Canadian (TSX) Pharma Industry Analysis

UpdatedDec 01, 2022
DataAggregated Company Financials
Companies133
  • 7D-0.6%
  • 3M-5.1%
  • 1Y-49.0%
  • YTD-46.6%

The Pharma is pretty flat in the last 7 days, but Canopy Growth has stood out, gaining 4.1%. As for the longer term, the industry has declined 49% in the last year. Earnings are forecast to grow by 63% annually.

Industry Valuation and Performance

Has the Canadian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 01 Dec 2022CA$30.0bCA$13.6b-CA$10,227,799,944.007.9x-2.9x2.2x
Sat, 29 Oct 2022CA$27.3bCA$13.4b-CA$9,392,010,364.0011.2x-2.9x2x
Mon, 26 Sep 2022CA$25.4bCA$13.3b-CA$9,378,656,286.0011.2x-2.7x1.9x
Wed, 24 Aug 2022CA$29.2bCA$13.0b-CA$8,889,532,298.0014.4x-3.3x2.3x
Fri, 22 Jul 2022CA$29.5bCA$12.2b-CA$5,871,331,170.0011.5x-5x2.4x
Sun, 19 Jun 2022CA$27.6bCA$12.3b-CA$5,816,615,635.008.2x-4.7x2.2x
Tue, 17 May 2022CA$32.9bCA$12.1b-CA$5,694,777,654.009.9x-5.8x2.7x
Thu, 14 Apr 2022CA$41.1bCA$11.7b-CA$4,556,779,578.0012.3x-9x3.5x
Sat, 12 Mar 2022CA$39.4bCA$10.9b-CA$4,366,226,079.0012.4x-9x3.6x
Mon, 07 Feb 2022CA$48.7bCA$10.9b-CA$4,918,116,940.0012.1x-9.9x4.4x
Wed, 05 Jan 2022CA$53.0bCA$10.9b-CA$4,960,187,003.0012.7x-10.7x4.9x
Fri, 03 Dec 2021CA$56.0bCA$10.9b-CA$4,731,747,038.0015.4x-11.8x5.1x
Sun, 31 Oct 2021CA$58.5bCA$10.2b-CA$4,802,813,625.0015.2x-12.2x5.8x
Tue, 28 Sep 2021CA$69.0bCA$10.3b-CA$6,645,321,538.0017.2x-10.4x6.7x
Thu, 26 Aug 2021CA$68.7bCA$10.2b-CA$6,616,236,433.2722.1x-10.4x6.7x
Fri, 02 Jul 2021CA$83.0bCA$10.2b-CA$6,613,771,569.2724.2x-12.5x8.1x
Mon, 05 Apr 2021CA$88.7bCA$8.8b-CA$7,557,962,787.4023.8x-11.7x10x
Thu, 07 Jan 2021CA$57.0bCA$7.0b-CA$8,796,767,091.1925.1x-6.5x8.1x
Wed, 30 Sep 2020CA$35.8bCA$6.4b-CA$10,187,973,751.0324.5x-3.5x5.6x
Sat, 04 Jul 2020CA$33.7bCA$5.5b-CA$8,871,002,112.2220.7x-3.8x6.1x
Tue, 07 Apr 2020CA$27.2bCA$5.2b-CA$6,469,124,222.039.8x-4.2x5.2x
Fri, 10 Jan 2020CA$39.3bCA$4.3b-CA$4,615,997,528.2815.8x-8.5x9.2x
Price to Earnings Ratio

-13.3x


Total Market Cap: CA$38.3bTotal Earnings: -CA$2,870,322,250.73Total Revenue: CA$3.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Pharma Industry Price to Earnings3Y Average -7.6x202020212022
Current Industry PE
  • Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 6.2x is higher than the industry's current PS ratio of 2.2x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 54% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market0.70%
Healthcare0.36%
Pharma-0.63%
Pharma-0.63%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
WEED Canopy GrowthCA$4.864.1%
+CA$92.3m
-61.9%PS4.9x
CURA Curaleaf HoldingsCA$8.980.6%
+CA$35.9m
-21.6%PS3.6x
TRUL Trulieve CannabisCA$17.561.0%
+CA$33.5m
-47.7%PS1.9x
HLS HLS TherapeuticsCA$9.588.4%
+CA$24.0m
-36.1%PS3.7x
LOVE Cannara BiotechCA$0.1226.3%
+CA$21.9m
0%PE45.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

TER

CA$2.55

TerrAscend

7D

-4.5%

1Y

-67.1%

FFNT

CA$0.61

4Front Ventures

7D

-4.7%

1Y

-54.5%

GSD

CA$0.41

Devonian Health Group

7D

36.7%

1Y

2.5%

LOVE

CA$0.12

Cannara Biotech

7D

26.3%

1Y

0%

CL

CA$4.45

Cresco Labs

7D

-2.8%

1Y

-56.5%

CCHW

CA$2.22

Columbia Care

7D

-5.1%

1Y

-42.5%

IAN

CA$0.045

iAnthus Capital Holdings

7D

-25.0%

1Y

-78.6%

DMT

CA$0.10

Small Pharma

7D

-32.3%

1Y

-73.8%

VRNO

CA$7.00

Verano Holdings

7D

-6.8%

1Y

-46.0%

GUD

CA$5.40

Knight Therapeutics

7D

3.3%

1Y

3.6%

CRON

CA$4.16

Cronos Group

7D

1.0%

1Y

-23.0%

TRUL

CA$17.56

Trulieve Cannabis

7D

1.0%

1Y

-47.7%

WEED

CA$4.86

Canopy Growth

7D

4.1%

1Y

-61.9%

CURA

CA$8.98

Curaleaf Holdings

7D

0.6%

1Y

-21.6%